Literature DB >> 16360036

hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.

Abdeladim Moumen1, Philip Masterson, Mark J O'Connor, Stephen P Jackson.   

Abstract

In response to DNA damage, mammalian cells trigger the p53-dependent transcriptional induction of factors that regulate DNA repair, cell-cycle progression, or cell survival. Through differential proteomics, we identify heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR. Induction of hnRNP K ensues through the inhibition of its ubiquitin-dependent proteasomal degradation mediated by the ubiquitin E3 ligase HDM2/MDM2. Strikingly, hnRNP K depletion abrogates transcriptional induction of p53 target genes and causes defects in DNA-damage-induced cell-cycle-checkpoint arrests. Furthermore, in response to DNA damage, p53 and hnRNP K are recruited to the promoters of p53-responsive genes in a mutually dependent manner. These findings establish hnRNP K as a new HDM2 target and show that, by serving as a cofactor for p53, hnRNP K plays key roles in coordinating transcriptional responses to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360036     DOI: 10.1016/j.cell.2005.09.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  152 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  p53 targets identified by protein expression profiling.

Authors:  Rubaiyat Rahman-Roblick; Uwe Johannes Roblick; Ulf Hellman; Paolo Conrotto; Tao Liu; Susanne Becker; Daniel Hirschberg; Hans Jörnvall; Gert Auer; Klas G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

3.  Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.

Authors:  Moubin Lin; Cathy Eng; Ernest T Hawk; Maosheng Huang; Anthony J Greisinger; Jian Gu; Lee M Ellis; Xifeng Wu; Jie Lin
Journal:  Carcinogenesis       Date:  2012-02-08       Impact factor: 4.944

4.  p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene.

Authors:  A Hari Kishore; Kiran Batta; Chandrima Das; Shipra Agarwal; Tapas K Kundu
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

5.  RNA-based affinity purification reveals 7SK RNPs with distinct composition and regulation.

Authors:  J Robert Hogg; Kathleen Collins
Journal:  RNA       Date:  2007-04-24       Impact factor: 4.942

6.  Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription.

Authors:  Kyunghwan Kim; Jongkyu Choi; Kyu Heo; Hyunjung Kim; David Levens; Kimitoshi Kohno; Edward M Johnson; Hugh W Brock; Woojin An
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

7.  Proteomic and genomic analysis of PITX2 interacting and regulating networks.

Authors:  Yue Huang; Kan Huang; Goran Boskovic; Yulia Dementieva; James Denvir; Donald A Primerano; Guo-Zhang Zhu
Journal:  FEBS Lett       Date:  2009-01-25       Impact factor: 4.124

8.  SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.

Authors:  Seong Won Lee; Moon Hee Lee; Jong Ho Park; Sung Hwan Kang; Hee Min Yoo; Seung Hyun Ka; Young Mi Oh; Young Joo Jeon; Chin Ha Chung
Journal:  EMBO J       Date:  2012-10-23       Impact factor: 11.598

9.  Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.

Authors:  Liqing He; Xiaochang Xue; Zhengjun Wang; Entai Hou; Yong Liu; Mingyu Liang; Yingqi Zhang; Zhongmin Tian
Journal:  Biochimie       Date:  2014-12-10       Impact factor: 4.079

10.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

Authors:  Renyuan Zhou; Reneé Shanas; Mark A Nelson; Achyut Bhattacharyya; Jiaqi Shi
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.